DGX Quest Diagnostics PE ratio, current and historical analysis
As of Apr 1, 2025, the DGX stock has a PE ratio of 21.76. The calculation is based on the latest EPS of $7.78 and the stock price of $169.28 per share. An increase of 15% has been observed in the PE ratio compared to its average of 19.0 of the last four quarters.
DGX PE ratio history
The mean historical PE ratio of Quest Diagnostics over the last ten years is 16.2. The current 21.76 P/E ratio is 34% higher than the historical average. Looking back at the last ten years, DGX's PE ratio peaked in the Jun 2017 quarter at 21.88, with a price of $111.16 and an EPS of $5.08. The Jun 2021 quarter marked the lowest point at 7.74, with a price of $131.97 and an EPS of $17.06.
Quest Diagnostics PE ratio by year
Maximum annual increase: 82.59% in 2014
Maximum annual decrease: -42.57% in 2013
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 19.39 | 6.71% | $150.86 | $7.78 |
| 2023 | 18.17 | -5.9% | $137.88 | $7.59 |
| 2022 | 19.31 | 76.83% | $156.44 | $8.1 |
| 2021 | 10.92 | -2.67% | $173.01 | $15.85 |
| 2020 | 11.22 | -33.17% | $119.17 | $10.62 |
| 2019 | 16.79 | 8.67% | $106.79 | $6.36 |
| 2018 | 15.45 | -11.66% | $83.27 | $5.39 |
| 2017 | 17.49 | -12.86% | $98.49 | $5.63 |
| 2016 | 20.07 | 38.8% | $91.9 | $4.58 |
| 2015 | 14.46 | -17.42% | $71.14 | $4.92 |
| 2014 | 17.51 | 82.59% | $67.06 | $3.83 |
| 2013 | 9.59 | -42.57% | $53.54 | $5.58 |
| 2012 | 16.7 | -15.14% | $58.27 | $3.49 |
| 2011 | 19.68 | 48.75% | $58.06 | $2.95 |
| 2010 | 13.23 | -14.31% | $53.97 | $4.08 |
Quest Diagnostics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 19.39 | -6.06% | $150.86 | $7.78 |
| Sep 2024 | 20.64 | 13.1% | $155.25 | $7.52 |
| Jun 2024 | 18.25 | 3.22% | $136.88 | $7.5 |
| Mar 2024 | 17.68 | -2.7% | $133.11 | $7.53 |
| Dec 2023 | 18.17 | 1.4% | $137.88 | $7.59 |
| Sep 2023 | 17.92 | -10.62% | $121.86 | $6.8 |
| Jun 2023 | 20.05 | -1.81% | $140.56 | $7.01 |
| Mar 2023 | 20.42 | 5.75% | $141.48 | $6.93 |
| Dec 2022 | 19.31 | 63.51% | $156.44 | $8.1 |
| Sep 2022 | 11.81 | 9.25% | $122.69 | $10.39 |
| Jun 2022 | 10.81 | 21.19% | $132.98 | $12.3 |
| Mar 2022 | 8.92 | -18.32% | $136.86 | $15.35 |
| Dec 2021 | 10.92 | 27.57% | $173.01 | $15.85 |
| Sep 2021 | 8.56 | 10.59% | $145.31 | $16.97 |
| Jun 2021 | 7.74 | -19.21% | $131.97 | $17.06 |
DGX average PE ratio chart
DGX's current PE ratio is higher than the 3, 5 and 10-year averages.
DGX PE vs peers
DGX's PE ratio stands lower than its peer stocks LH and QGEN.
| Stock name | PE ratio | Market cap |
|---|---|---|
| DGX Quest Diagnostics Inc | 21.76 | $18.79B |
| LH Laboratory Corp Of America Holdings | 26.17 | $19.47B |
| QGEN Qiagen NV | 103.95 | $8.78B |
| NEO Neogenomics Inc | N/A | $1.2B |
| ENZ Enzo Biochem Inc | N/A | $17.82M |
Frequently asked questions
What is Quest Diagnostics's PE ratio?
DGX's price to earnings ratio is 21.76 as of Apr 1, 2025.
What is the 3-year average PE ratio for Quest Diagnostics (DGX)?
Over the last 3 years, the average price to earnings ratio for DGX stock is 17.68.
What is the 5-year average PE ratio for Quest Diagnostics (DGX)?
Over the last 5 years, the average price to earnings ratio for DGX stock is 15.04.
What is the highest PE ratio for DGX?
Over the last ten years, the Jun 2017 quarter recorded the highest quarterly PE ratio at 21.88.
How does the current PE ratio for DGX compare to its historical average?
DGX's current price to earnings ratio is 34% above its 10-year historical average.
How is DGX's PE ratio calculated (Quest Diagnostics PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Apr 1, 2025), Quest Diagnostics's share price is $169.28. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $7.78. Therefore, Quest Diagnostics's PE ratio for today is 21.76. PE RATIO(21.76) = STOCK PRICE($169.28) / TTM EPS($7.78)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.